News and Updates
Rocky Mountain Life Sciences Investor and Partnering Conference
Great day in Colorado! Reglagene CEO Richard Austin pitches to a full house.
Tech Nation Radio Interview
Listen to Dr. Moira Gunn interview Reglagene's CEO Richard Austin about the process of advancing their medicines into clinical trials.
Company Presentation at BIO
It's been a great start to #BIO2022! Reglagene's CEO Richard Austin presented at the BIO International Conference to a full house.
Viva Biotech 2022 Partnership Summit
Reglagene's CEO Richard Austin will be presenting at the Viva Biotech Demo Day on June 15th. Hope to see you there!
Richard Austin Panelist at Life Science Nation's RESI Conference
Reglagene's CEO Richard Austin will be a panelist at the Life Science Nation (LSN) RESI conference. We hope to see you there!
Desert Angels Featured in BizTucson
Desert Angels CEO Joann MacMaster discusses how they changed their operations during the pandemic to help new and existing portfolio companies.
BizBites Tucson Interview
Thank you to Amanda Bruno and our friends at the City of Tucson for featuring Reglagene.
Dr. Hurley Honored in Special Issue of Medicinal Chemistry Research
Hot off the press! Our very own Chief Scientific Officer Dr. Laurence Hurley honored in a special issue.
A Warm Congratulations to Dr. Laurence Hurley
Congratulations to Reglagene's Chief Scientific Officer Dr. Laurence Hurley for the granting of FDA Fast Track status for Pidnarulex, the only DNA quadruplex-targeting therapy that is active in human clinical trials.